Basic information
- CAS
14769-73-4- Standard SMILES
c1ccc([C@H]2CN3CCSC3=N2)cc1- InChIKey
HLFSDGLLUJUHTE-SNVBAGLBSA-N- Molecular formula
- C11H12N2S
- Average molar mass
- 204.29 g/mol
- Monoisotopic mass
- 204.07211956
Names & identifiers
- Preferred name
- Levamisole
- IUPAC
- (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole
- English name
- Levamisole
- Molecular formula
- C11H12N2S
- Molecular weight
- 204.29
Names & synonyms
Show more names
Database identifiers
- CAS
14769-73-4- PubChem CID
- 26879
- DTXSID
DTXSID4023206- ChEMBL
CHEMBL1454- ChEBI
CHEBI:6432- UNII
- 2880D3468G
- EC Number
- 238-836-5
- Nikkaji
- J8.518I
Properties
Computed structural properties
- XLogP
- 1.8
- Topological polar surface area
- 40.9 Ų
- Hydrogen bond donors
- 0
- Hydrogen bond acceptors
- 2
- Rotatable bonds
- 1
- Heavy atoms
- 14
- Formal charge
- 0
- Complexity
- 246
Physicochemical properties
- Melting point
- 60 · 60-61.5°
- alpha
- 25 · D25 -85.1° (c = 10 in chloroform)
- Boiling point
- 344.4 · 344.4±45.0 °C(Predicted)
- Density
- 1.32 · 1.32±0.1 g/cm3(Predicted)
- storage temp.
- 2 · Sealed in dry,2-8°C
- solubility
- Chloroform (Slightly), Methanol (Slightly)
- form
- Solid
- pka
- 10 · 10.00±0.40(Predicted)
- color
- Off-White to Pale Yellow
- InChI
- InChI=1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2/t10-/m1/s1
- InChIKey
- HLFSDGLLUJUHTE-SNVBAGLBSA-N
- SMILES
- S1CCN2C[C@H](C3=CC=CC=C3)N=C12
- CAS DataBase Reference
- 14769 · 14769-73-4(CAS DataBase Reference)
- FDA 21 CFR
- 556.35 · 556.350
- FDA UNII
- 2880 D3468G · 2880D3468G
- NCI Dictionary of Cancer Terms
- levamisole
- ATC code
- 2 CE01 · P02CE01
- EPA Substance Registry System
- Levamisole (14769-73-4)
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 302 · H302+H312+H332-H315-H319-H335
- Precautionary statements
- 261 · P261-P264b-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362+P364-P403+P233-P501c
Safety & regulation
Safety data
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- Hazard statements
- H302+H312+H332-H315-H319-H335
- Precautionary statements
- P261-P264b-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362+P364-P403+P233-P501c
Chemistry & industry
Applications
UsesLevamisole is used for initial and secondary immunodeficient conditions, autoimmune diseases, chronic and reoccurring infections, large intestine adenocarcinoma, helmintosis, and rheumatoid arthritis. Synonyms of this drug are decaris, tetramizole, and others.Levimasole is also a drug of choice for ascardiasis. Numerous investigations show that a single dose of levamisole heals from 90 to 100% of patients with ascardiasis, in particular those infected with A. duodenale. It is less effective against ancylostomiasis and strongyloidiasis. However, it is not effective against N. americanus. It seems likely that it has a gangliostimulating effect on parasite tissues in both the parasympathetic and sympathetic regions. Moreover, it is presumed that this drug has an immunomodulatory effect on the host organism. Synonyms of this drug are decaris, solacil, ergamisol, tramisol, immunol, and others.
UsesBiological response modifier.
Upstream & downstream products
Upstream raw materials
Downstream products
Suppliers100 total
Additional notes
DefinitionChEBI: Levamisole is a 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole that has S configuration. It is used (generally as the monohydrochloride salt) to treat parasitic worm infections in pigs, sheep and cattle and was formerly used in humans as an adjuvant to chemotherapy for the treatment of various cancers. It is also widely used as an adulterant to coccaine. It has a role as an antinematodal drug, an antirheumatic drug, an immunomodulator, an immunological adjuvant and an EC 3.1.3.1 (alkaline phosphatase) inhibitor. It is an enantiomer of a dexamisole.
Related reactions
Compound notes
Loading…